Tuesday said that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to mavorixafor, an oral CXCR4 antagonist, for the treatment of chronic neutropenia.

Cybercriminals are exploiting fake links on X to hijack wallets and drain crypto. Learn how these scams work, see real-world examples and find out how to spot and avoid them.

ARSENAL are looking ahead to a busy summer transfer window after another trophyless season. Al-Hilal are interested in ...